CHCF Funding Cliff: Dec 31 Deadline
December 11, 2026. That is when federal government funding runs out. 🗓️ Then, 20 days later on December 31, the Community Health Center Fund expires. Two deadlines. One lame-duck Congress. And community health centers stuck in the middle of a budget fight they did not create. According to Legal 500, Congress returns after the midterms facing a December 11 deadline when the current continuing resolution (CR) expires. The lame-duck session will also require action on healthcare programs and other expiring authorities before adjournment. The math is brutal: 🔹 The House passed only 3 of the 12 FY 2027 appropriations bills before the pre-election recess. 🔹 The Senate completed no comparable floor action at all. 🔹 A partial government shutdown remains ...
$50B Rural Health: CON Laws in the Crosshairs
A state capitol hearing room, sometime this spring. Tennessee lawmakers vote, in a bipartisan majority, to unravel most of their certificate of need rules. They had a funding incentive to do it. They did it anyway. That is the story most people are missing right now. 🏥 According to KFF Health News, the Trump administration has tied part of the $50 billion five-year Rural Health Transformation Program to whether states end or loosen their certificate of need, or CON, laws. CMS called these laws, verbatim, "an additional expense and burden on rural facilities." Six states have already said in their applications that they would revisit their laws. And the reaction from healthcare advocates has been almost entirely negative. I think ...
Baba $40M Series A: Medicare AI + Humans
Everyone said AI would replace care coordinators. Baba raised $40M to hire more of them. 🏥 That contrast is exactly what makes this round worth paying attention to. Baba, the New York-based applied AI company, closed a $40 million Series A this week led by FirstMark Capital. CVS Health Ventures and Valtruis joined the round alongside returning investors General Catalyst, Genius Ventures, and Ground Up Ventures. The pitch is not automation in the traditional sense. Baba gives each Medicare and Medicaid member a dedicated team of care advocates and licensed therapists, backed by AI that connects medical, financial, social, and behavioral health needs into one workflow. The human stays in the loop. The AI makes that human faster, more informed, ...
The ELCAP Stage I Survival Framework
92% 10-year lung cancer-specific survival when stage I disease got prompt surgical resection. 🎯 That number, from I-ELCAP's 2006 New England Journal of Medicine report, is the entire argument for low-dose CT screening in one stat. According to The ASCO Post, the I-ELCAP program screened 31,567 people and identified 484 lung cancers. 85% of those were clinical stage I. The estimated 10-year lung cancer-specific survival for stage I patients was 88% overall. Among those who underwent prompt surgical resection, it hit 92%. That is not incremental. That is the difference between a fatal disease and a curable one. The original ELCAP findings, published in The Lancet in 1999, showed that low-dose CT detected substantially more early lung cancers than chest ...
Minnesota FQHCs: $100M Loss by 2030
$100.3 million. That's what H.R. 1 costs Minnesota's FQHCs by 2030. 🧮 I read that number in a new report from Facktor and Capital Link, commissioned by the Minnesota Association of Community Health Centers. And I sat with it for a minute. These are 17 clinics. Seventeen. They run more than 80 sites across the state, serving nearly 200,000 low-income Minnesotans in urban and rural settings, regardless of insurance status or ability to pay. That is the safety-net doing exactly what it is supposed to do. Now watch what happens when the policy environment shifts beneath them. 🔹 More than 71,000 patients are at risk of losing health coverage over the next four years. 🔹 The projected revenue loss totals ...
FFR-IQ AI: Cardiac CT Without the Cath Lab
Everyone's calling this a cardiology story. I think it's a radiology story. The FDA just cleared Elucid's FFR-IQ software, an AI-powered tool that estimates fractional flow reserve directly from coronary CT angiography scans. No catheterization required. According to Diagnostic Imaging, a recent study of FFR-IQ showed 92.2 percent sensitivity and 93.1 percent specificity for non-invasive FFR estimation from CCTA images. Those numbers matter. But what matters more is what they represent. For decades, the gold standard for assessing whether a coronary lesion is functionally significant has been invasive FFR, a wire-based pressure measurement done during catheterization. That procedure carries real procedural risk, real cost, and real patient burden. This clearance says: a CT scan and an algorithm can now do ...
E-Prior Auth Expands to Self-Funded Plans
What does your doctor do while waiting on a prior auth fax? They wait. Your patient waits. And care gets delayed for no clinical reason. This week, CMS and the Department of Labor announced that five major employers signed a statement of support to expand electronic prior authorization to self-funded health plans. According to U.S. Census data cited in the announcement, more than 53% of Americans, over 180 million people, receive their health coverage through employers that sponsor self-funded health plans. The employers who signed on: 🔹 Amazon 🔹 Google 🔹 Meta 🔹 Axon Enterprise 🔹 Oracle Corporation These are not small players dabbling in benefits policy. These are companies whose combined workforce touches hundreds of thousands of Americans. 💡 ...
142,250 People, One Missed Endpoint: What the FDA Galleri Vote Actually Tells Us
This is the detailed version of MCED Blood Tests: The Screening Revolution. The largest multi-cancer screening trial in history missed its primary goal. The FDA panel voted 7 to 2 to approve anyway. Here is what the evidence actually shows and what health systems need to plan for. On September 23, 2026, an FDA advisory panel voted to recommend approval of GRAIL's Galleri blood test for multi-cancer early detection. The vote that drew headlines was 7 to 2, with one abstention, that benefits outweigh risks. Two other votes happened the same day: 10 to 0 that the test is safe, and 6 to 4 that it is effective. The 6-to-4 vote on effectiveness is the one that matters for every ...
Lung Screening Criteria Miss Minority Patients
The lung cancer screening rulebook was built for white patients. 🔬 That is not an accusation. It is what the data in Annals of Internal Medicine now confirm. A study using Multiethnic Cohort data, published this week, examined what happens when you replace the traditional pack-year lung cancer screening threshold with a smoking-duration criterion. The results expose a structural gap that has been quietly excluding millions of people from early detection. Under the current 2021 U.S. Preventive Services Task Force criteria, screening eligibility across racial and ethnic groups looks like this: 🔹 White participants: 30.2% eligible 🔹 Native Hawaiian participants: 25.1% eligible 🔹 Japanese American participants: 25.5% eligible 🔹 African American participants: 21.4% eligible 🔹 Latino participants: 15.7% eligible After ...